Remegen is led by a visionary management team with an average of more than 20 years of industry experience. They also have proven track records of innovative drug R&D, clinical development and commercialization.
We are constituting a professional excellent talent team composed of more than one thousand people.
Dr. Jianmin Fang possesses rich R&D experience on developing innovative biological drugs in famous research institutions and biopharmaceutical companies. Led by Dr. Fang, RemeGen has established a strong research and development team, covering all major functions involved in the development of biologic drugs.
Under the leadership of Dr. Ruyi He, our Chief Medical Officer, RemeGen has built a development team responsible for executing our global clinical development plan while adhering to rigorous trial design and trial operational excellence.
In the spirit of following where the data leads, our clinical development team often discovers and explores unanticipated clinical opportunities, which in turn spur the organic growth and expansion of our clinical program and pipeline.